Celebrating Our Successes of 2024
As 2024 draws to a close, we’re reflecting on an incredible year for our team. Since formally moving to QMUL at the end of 2023… Read More »Celebrating Our Successes of 2024
Cervical Cancer
Better Together: Joining forces to eliminate cervical cancer
Dr Matejka Rebolj and Jane Rigney, from the Centre for Cancer Screening, Prevention and Early Diagnosis, Queen Mary University of London, lend their reflections on the meeting… Read More »Better Together: Joining forces to eliminate cervical cancer
Treatment for locally advanced cervical cancer: INTERLACE
A phase III multicentre trial of weekly induction chemotherapy followed by standard chemoradiation versus standard chemoradioation alone, in patients with locally advanced cervical cancer Aim:… Read More »Treatment for locally advanced cervical cancer: INTERLACE
2023 Christmas Reading List
Marking the end of another busy year for the Cancer Prevention Group, we have hand picked 15 of our published research highlights for your festive… Read More »2023 Christmas Reading List
CanScreen5: A programme to improve the quality of cancer screening programmes
CanScreen5 Cancer Screening in Five Continents (CanScreen5) is a project analysing the organisation and implementation of breast, cervical and colorectal cancer screening programmes worldwide. It… Read More »CanScreen5: A programme to improve the quality of cancer screening programmes
PROTECT-EUROPE: Vaccinating Europe to protect against HPV
This piece was co-written by Margaret Stanley, Daniel Kelly and Peter Baker (full biographies at the bottom of this piece). HPV, cancer cases and gender-neutral… Read More »PROTECT-EUROPE: Vaccinating Europe to protect against HPV